SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-09-202841
Filing Date
2009-10-02
Accepted
2009-10-02 17:07:19
Documents
8
Period of Report
2009-10-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 19948
2 OPINION OF AKERMAN SENTERFITT dex51.htm EX-5.1 6723
3 ENGAGEMENT LETTER dex101.htm EX-10.1 83842
4 FORM OF SECURITIES PURCHASE AGREEMENT dex102.htm EX-10.2 131767
5 PRESS RELEASE ISSUED BY THE COMPANY ON OCTOBER 1, 2009 dex991.htm EX-99.1 9187
6 GRAPHIC g74701ex991.jpg GRAPHIC 10754
7 GRAPHIC g74701g21w45.jpg GRAPHIC 4827
8 GRAPHIC g74701g48z55.jpg GRAPHIC 13092
  Complete submission text file 0001193125-09-202841.txt   292971
Mailing Address 220 MIRACLE MILE SUITE 234 CORAL GABLES FL 33134
Business Address 220 MIRACLE MILE SUITE 234 CORAL GABLES FL 33134 (305) 529-2522
Catalyst Pharmaceutical Partners, Inc. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33057 | Film No.: 091103280
SIC: 2834 Pharmaceutical Preparations